Mark G. Swain

21.1k total citations · 3 hit papers
329 papers, 11.7k citations indexed

About

Mark G. Swain is a scholar working on Hepatology, Epidemiology and Astronomy and Astrophysics. According to data from OpenAlex, Mark G. Swain has authored 329 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Hepatology, 114 papers in Epidemiology and 77 papers in Astronomy and Astrophysics. Recurrent topics in Mark G. Swain's work include Liver Disease Diagnosis and Treatment (94 papers), Liver Diseases and Immunity (61 papers) and Stellar, planetary, and galactic studies (57 papers). Mark G. Swain is often cited by papers focused on Liver Disease Diagnosis and Treatment (94 papers), Liver Diseases and Immunity (61 papers) and Stellar, planetary, and galactic studies (57 papers). Mark G. Swain collaborates with scholars based in Canada, United States and United Kingdom. Mark G. Swain's co-authors include Charlotte D’Mello, Tai Le, Abdel Aziz Shaheen, Gilaad G. Kaplan, G. Tinetti, Maureen N. Ajuebor, Gautam Vasisht, Stephen E. Congly, Kiarash Riazi and Fox E. Underwood and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Neuroscience.

In The Last Decade

Mark G. Swain

314 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

2022 1.3k citations Mark G. Swain, Stephen E. Congly et al. profile →
Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation

2009 547 citations Mark G. Swain et al. profile →
Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis

2021 374 citations Stephanie Coward, Steven J. Heitman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark G. Swain Canada	57	4.5k	3.7k	1.7k	1.5k	1.3k	329	11.7k
Joan Clària Spain	60	4.6k 1.0×	3.7k 1.0×	2.3k 1.4×	2.1k 1.5×	1.1k 0.9×	317	13.2k
D. I. Jones United Kingdom	60	2.8k 0.6×	3.1k 0.8×	1.6k 0.9×	2.7k 1.8×	566 0.5×	329	12.4k
Andreas Teufel Germany	39	1.4k 0.3×	1.2k 0.3×	470 0.3×	167 0.1×	592 0.5×	184	6.6k
Atsushi Nakajima Japan	71	8.1k 1.8×	3.6k 1.0×	4.9k 2.9×	185 0.1×	1.4k 1.1×	788	20.2k
Robert P. Myers United States	81	10.4k 2.3×	8.2k 2.2×	5.8k 3.5×	145 0.1×	401 0.3×	330	24.1k
Akira Ichihara Japan	60	1.8k 0.4×	3.3k 0.9×	2.6k 1.6×	40 0.0×	1.1k 0.9×	263	15.8k
A. Fontana Italy	94	2.0k 0.4×	247 0.1×	1.4k 0.8×	6.5k 4.5×	10.2k 8.1×	514	32.9k
Takashi Uchiyama Japan	54	1.1k 0.2×	297 0.1×	1.2k 0.7×	196 0.1×	4.9k 3.9×	336	12.0k
Paolo Bernardi Italy	93	2.9k 0.6×	446 0.1×	1.5k 0.9×	81 0.1×	1.4k 1.1×	375	32.8k
Ellen Gelpí Spain	53	1.4k 0.3×	140 0.0×	702 0.4×	195 0.1×	1.1k 0.9×	310	14.5k

Countries citing papers authored by Mark G. Swain

Since Specialization

Citations

This map shows the geographic impact of Mark G. Swain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Swain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Swain more than expected).

Fields of papers citing papers by Mark G. Swain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Swain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Swain. The network helps show where Mark G. Swain may publish in the future.

Co-authorship network of co-authors of Mark G. Swain

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Swain. A scholar is included among the top collaborators of Mark G. Swain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Swain. Mark G. Swain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stangret, M., Mark G. Swain, J. Orell-Miquel, et al.. (2025). Exploring the atmosphere of GJ 1132 b with CRIRES+. Astronomy and Astrophysics. 697. A31–A31. 1 indexed citations

Wilson, Mitchell P., Gavin Low, Alexandra Medellin, et al.. (2025). Part 3: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality Assurance. Canadian Association of Radiologists Journal. 77(1). 85–97. 2 indexed citations

Wilson, Mitchell P., Gavin Low, Abdel Aziz Shaheen, et al.. (2025). Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD. Canadian Association of Radiologists Journal. 77(1). 73–84. 2 indexed citations

Sebastiani, Giada, et al.. (2025). Sex differences in the prevalence and cardiometabolic risk profiles of steatotic liver disease: A Canadian Longitudinal Study on Aging analysis. Canadian Journal of Public Health. 117(1). 167–182. 3 indexed citations

Raggi, Paolo, et al.. (2025). A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada. Diabetes Obesity and Metabolism. 27(12). 6831–6846.

Romano, Jacob, Giada Sebastiani, Alnoor Ramji, et al.. (2024). Examining the prevalence of hepatic steatosis and advanced fibrosis using non-invasive measures across Canada: A national estimate using the Canadian Health Measures Survey (CHMS) from 2009-2019. Annals of Hepatology. 30(1). 101757–101757. 2 indexed citations

Raggi, Paolo, et al.. (2024). Metabolic dysfunction-associated steatotic liver disease: An opportunity for collaboration between cardiology and hepatology. Atherosclerosis. 392. 117523–117523. 6 indexed citations

Younossi, Zobair M., Andreas E. Kremer, Mark G. Swain, et al.. (2024). Assessment of fatigue and its impact in chronic liver disease. Journal of Hepatology. 81(4). 726–742. 11 indexed citations

Coward, Stephanie, Abdel Aziz Shaheen, Mark G. Swain, et al.. (2023). Incidence and Prevalence of Primary Sclerosing Cholangitis: A Meta-analysis of Population-based Studies. Inflammatory Bowel Diseases. 30(11). 2019–2026. 7 indexed citations

10.

Roudier, Gaël, et al.. (2021). Disequilibrium Chemistry in Exoplanet Atmospheres Observed with the Hubble Space Telescope. The Astronomical Journal. 162(2). 37–37. 26 indexed citations

11.

Shaheen, Abdel Aziz, Henry H. Nguyen, Stephen E. Congly, Gilaad G. Kaplan, & Mark G. Swain. (2019). Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver International. 39(5). 878–884. 41 indexed citations

12.

Shaheen, Abdel Aziz, Gilaad G. Kaplan, Isabelle A. Vallerand, et al.. (2018). The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. PLoS ONE. 13(4). e0194839–e0194839. 20 indexed citations

13.

Younossi, Zobair M., Maria Stepanova, Tarik Asselah, et al.. (2017). Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes. Clinical Infectious Diseases. 66(11). 1742–1750. 18 indexed citations

14.

Tsolakis, Apostolos V., Paul D. James, Gilaad G. Kaplan, et al.. (2016). Clinical prediction rule to determine the need for repeat ERCP after endoscopic treatment of postsurgical bile leaks. Gastrointestinal Endoscopy. 85(5). 1047–1056.e1. 4 indexed citations

15.

Cook, T., Kerri Cahoy, Nikole K. Lewis, et al.. (2014). Planetary Imaging Concept Testbed Using a Recoverable Experiment - Coronagraph. 224. 1 indexed citations

16.

Deroo, Pieter, Mark G. Swain, G. Tinetti, et al.. (2010). Thesis: A Combined-light Mission For Exoplanet Molecular Spectroscopy. 215. 1 indexed citations

17.

Swain, Mark G.. (2010). Finesse - A New Mission Concept For Exoplanet Spectroscopy. DPS. 2 indexed citations

18.

Absil, Olivier, et al.. (2007). Nulling interferometry: performance comparison between Antarctica and other\nground-based sites. Springer Link (Chiba Institute of Technology). 3 indexed citations

19.

Bain, Vincent G., K. Kaita, Eric M. Yoshida, et al.. (2007). [9] COMPARABLE ANTIVIRAL RESPONSE RATES WITH ALBUMIN INTERFERON ALFA-2B DOSED AT Q2W OR Q4W INTERVALS IN NAIVE SUBJECTS WITH GENOTYPE 2 OR 3 CHRONIC HEPATITIS C. Journal of Hepatology. 46. S7–S7. 3 indexed citations

20.

Bisceglie, Adrian M. Di, Hari S. Conjeevaram, Michael Fried, et al.. (1995). Ribavirin as Therapy for Chronic Hepatitis C. Annals of Internal Medicine. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact